New therapies vie to change the fatal course of amyotrophic lateral sclerosis
The BioWorld Insider Podcast06/03/22 • 33 min
Executives from Amylyx Pharmaceuticals Inc. and Clene Inc., along with a key Penn State ALS expert, discuss what the future of medicine holds for patients.
Hosted on Acast. See acast.com/privacy for more information.
06/03/22 • 33 min
Generate a badge
Get a badge for your website that links back to this episode
Select type & size
<a href="https://goodpods.com/podcasts/the-bioworld-insider-podcast-377776/new-therapies-vie-to-change-the-fatal-course-of-amyotrophic-lateral-sc-53974746"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to new therapies vie to change the fatal course of amyotrophic lateral sclerosis on goodpods" style="width: 225px" /> </a>
Copy